Published in J UOEH on September 01, 1995
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Propensity of ectopic liver to hepatocarcinogenesis: case reports and a review of the literature. Hepatology (1999) 3.29
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst (1993) 2.66
Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J (1992) 2.65
Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res (1987) 2.65
Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer: results of a pilot study. Chest (1999) 2.12
Gallstone ileus. Review of 112 patients in the Japanese literature. Am J Surg (1980) 1.95
Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer (1999) 1.94
Kawasaki disease in families. Pediatrics (1989) 1.83
Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology (2001) 1.82
Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol (2000) 1.81
Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem (2000) 1.80
The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol (1995) 1.74
Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res (1992) 1.72
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res (2000) 1.64
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene (2000) 1.63
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene (1992) 1.63
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol (2012) 1.63
Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol (2000) 1.57
Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer? Br J Cancer (2007) 1.55
Human-human hybridomas secreting antibodies specific to human lung carcinoma. In Vitro Cell Dev Biol (1985) 1.54
Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis. Ann Thorac Surg (1989) 1.53
Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. J Natl Cancer Inst (1993) 1.50
The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores. Am Rev Respir Dis (1990) 1.49
Fine structure of influenza A virus observed by electron cryo-microscopy. EMBO J (1994) 1.48
Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res (1999) 1.47
Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients. Hum Antibodies Hybridomas (1994) 1.46
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler (2008) 1.44
A human T-cell lymphotropic virus type-I carrier with chronic renal failure, aplastic anemia, myelopathy, uveitis, Sjögren's syndrome and panniculitis. Intern Med (1996) 1.43
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene (1992) 1.41
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res (1996) 1.41
Multiple free (aorta-coronary) gastroepiploic artery grafting. Ann Thorac Surg (1990) 1.40
Video-assisted thoracic surgery through a single skin incision. Arch Surg (1998) 1.40
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res (2001) 1.33
Selective interaction of triazole derivatives with DWF4, a cytochrome P450 monooxygenase of the brassinosteroid biosynthetic pathway, correlates with brassinosteroid deficiency in planta. J Biol Chem (2001) 1.33
Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res (1990) 1.33
Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg (1998) 1.32
An L1 element intronic insertion in the black-eyed white (Mitf[mi-bw]) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness. Hum Mol Genet (1999) 1.32
Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res (1996) 1.32
Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene (2007) 1.32
Regulation of CYP1A1 expression. FASEB J (1992) 1.31
Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium. Biochem Biophys Res Commun (1998) 1.30
Polymorphism at codon 213 within the p53 gene. Oncogene (1991) 1.30
Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc (2001) 1.29
Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking. Br J Cancer (2006) 1.29
Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol (1992) 1.25
Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun (1996) 1.24
Induction of chromosomal gene mutations in Escherichia coli by direct incorporation of oxidatively damaged nucleotides. New evaluation method for mutagenesis by damaged DNA precursors in vivo. J Biol Chem (1998) 1.23
The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem (1994) 1.22
Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg (2001) 1.22
Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta (1994) 1.22
Physical-strength tests and mortality among visitors to health-promotion centers in Japan. J Clin Epidemiol (1995) 1.21
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer (2001) 1.21
Carcinosarcoma and spindle cell carcinoma of the lung. Clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg (1990) 1.20
Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study. Am Heart J (1998) 1.19
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer (2004) 1.19
Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol (1996) 1.18
Differences in cardiovascular disease risk factors between Japanese in Japan and Japanese-Americans in Hawaii: the INTERLIPID study. J Hum Hypertens (2003) 1.17
Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res (1995) 1.17
Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm Res (1994) 1.17
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J (2011) 1.16
Trends in the incidence of hip fracture in Japan, 1987-1997: the third nationwide survey. J Bone Miner Metab (2000) 1.15
Identification of a gene for a polyamine transport protein in yeast. J Biol Chem (1999) 1.15
Mutations in the p53 gene in primary human breast cancers. Cancer Res (1991) 1.15
Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol (2007) 1.15
Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer (2000) 1.15
High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.14
Macular microcirculation and macular oedema in branch retinal vein occlusion. Br J Ophthalmol (2009) 1.13
A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1,630 cases. World J Surg (1989) 1.13
Radiotherapy for Kimura's disease: the optimum dosage. Int J Radiat Oncol Biol Phys (1998) 1.13
Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim Biophys Acta (2000) 1.12
Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol Int (1997) 1.12
Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res (2001) 1.12
Cell-specific translational control of transcription factor BTEB expression. The role of an upstream AUG in the 5'-untranslated region. J Biol Chem (1994) 1.10
Evaluation of coronary flow velocity dynamics and flow reserve in patients with Kawasaki disease by means of a Doppler guide wire. J Am Coll Cardiol (1998) 1.09
Cloning of the human DOPAchrome tautomerase/tyrosinase-related protein 2 gene and identification of two regulatory regions required for its pigment cell-specific expression. J Biol Chem (1994) 1.09
Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer (1991) 1.09
Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study. J Neurosurg (1978) 1.08
Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res (1996) 1.08
Fine structure of protein bodies isolated from rice endosperm. Arch Biochem Biophys (1969) 1.08
Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol (2000) 1.07
Identification of catalytic nucleophile of Escherichia coli gamma-glutamyltranspeptidase by gamma-monofluorophosphono derivative of glutamic acid: N-terminal thr-391 in small subunit is the nucleophile. Biochemistry (2000) 1.07
Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res (1996) 1.07
Embarking on rice functional genomics via cDNA microarray: use of 3' UTR probes for specific gene expression analysis. DNA Res (2000) 1.07
Transformation of coronary artery aneurysm to obstructive lesion and the role of collateral vessels in myocardial perfusion in patients with Kawasaki disease. J Am Coll Cardiol (1993) 1.06
Determinants of bone loss in a rural Japanese community: the Taiji Study. Osteoporos Int (1998) 1.06
K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Br J Cancer (1997) 1.05
High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res (2000) 1.04
Mucoepidermoid carcinoma of the larynx: a case which responded completely to radiotherapy and a review of the literature. Jpn J Clin Oncol (1998) 1.04
Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer (2001) 1.04
Relation of ST-segment changes in inferior leads during anterior wall acute myocardial infarction to length and occlusion site of the left anterior descending coronary artery. Am J Cardiol (2001) 1.03
Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer (2001) 1.03
Bone loss at the lumbar spine and the proximal femur in a rural Japanese community, 1990-2000: the Miyama study. Osteoporos Int (2002) 1.02
Regulation of pigment cell-specific gene expression by MITF. Pigment Cell Res (2000) 1.02
Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer. Anticancer Res (2001) 1.02
Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. Hum Antibodies (1997) 1.00